After undertaking a PhD in retinal research, Tim has retained an active international research profile.
Tim’s key area of research interest is the investigation of novel drugs and surgical devices for retinal disease, particularly age-related macular degeneration and diabetic eye disease.
He is Chief or Principle investigator on a number of national and international trials and currently holds an active research budget of approximately £6M. He leads one of the UK’s largest NIHR/MRC-funded randomised controlled trials of a retinal device and heads Europe’s largest non-commercial vitreoretinal surgical trial.
For further details visit the KCL website.